EVYD Technology and A*STAR Launch $8M Joint AI Research Lab to Revolutionize Healthcare Solutions

31 Jul 2023

Revolutionizing Healthcare: EVYD & A*STAR's $8M AI Research Lab

EVYD Technology and the Singaporean Agency for Science, Technology and Research (A*STAR) have teamed up to create an innovative AI research laboratory centered on improvements in population health and digital health. The partnership seeks to harness the potential of AI to strengthen healthcare solutions and make a positive influence on patient results.

The A*STAR-EVYD Joint Lab is set to address different healthcare obstacles, such as creating a system for gathering health-related information and assessing overall well-being to encourage healthy behaviors. Additionally, they will investigate the possibility of a health concierge service utilizing advanced language models, establish remote health monitoring to detect potential health problems at an early stage, and simplify diagnostic procedures to assist medical professionals in analyzing data and making accurate diagnoses.

Articles that are related: Singapore's first-ever antibody-drug conjugate, manufactured locally, has received the green light to proceed with clinical trials.

Singapore Leads In AI-Driven Healthcare

The alliance between EVYD Technology and A*STAR has profound implications for the future of healthcare. Through the fusion of their skills in AI exploration and medical assistance, the partnership aims to catalyze groundbreaking advancements in the industry. The creation of a personalized healthcare assistant and remote health surveillance capabilities can bring about a paradigm shift in patient wellbeing by enhancing treatment strategies and bolstering the effectiveness of healthcare providers' capacity management.

Photo www.geneonline.com

In addition, the application of diagnostic workflows powered by AI has the potential to improve the precision and effectiveness of data analysis, ultimately bringing advantages to both patients and medical professionals. This collaborative effort demonstrates the growing significance of AI in the healthcare industry and emphasizes Singapore's dedication to leading the way in digital health solutions.

A*STAR's Quest For Innovative Partnerships

The collaboration between EVYD Technology and ASTAR is not the initial one of its type involving the respected research agency. Previously, ASTAR also joined forces with Johnson & Johnson Vision to establish the Eye Health Digital Innovation Consortium, concentrating on progressing eye health research. This consortium, the first of its kind in the Asia-Pacific area, strives to tackle the urgent eye health requirements within the region and create inventive solutions utilizing technologies such as blockchain, AI, and data privacy safeguarding.

With the increasing number of people suffering from vision problems and nearsightedness in the Asia-Pacific area, it is extremely important to establish partnerships in order to create efficient and easily obtainable eye care solutions for the population. By joining forces with influential companies, A*STAR is playing a key role in propelling Singapore towards major achievements in the field of digital health and AI-driven healthcare innovations. This progress will have a positive impact on millions of individuals throughout the region.